0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$97.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
GLOW is a research peptide blend composed of three experimentally studied peptide sequences: GHK-Cu, BPC-157, and TB-500 (Thymosin Beta-4 fragment). The formulation is supplied for laboratory research examining peptide signaling interactions and multi-compound pathway investigation.
This combination format allows researchers to investigate peptide interactions across different signaling domains within controlled experimental systems. The blend may be used in studies exploring extracellular matrix dynamics, peptide–cell signaling interactions, and receptor pathway modulation.
Each batch is analytically verified through Certificate of Analysis (COA) documentation confirming molecular identity and purity of the peptide components.
This compound blend is supplied exclusively for laboratory research.
Research involving peptide blends may explore interactions across multiple cellular signaling pathways.
Published research involving the individual peptide components includes investigation of:
Studies involving peptide combinations may examine pathway cross-talk or comparative signaling responses within controlled in vitro systems.
All references relate strictly to experimental laboratory research.
GLOW peptide blend is supplied as a lyophilized powder.
Recommended handling procedures include:
All experimental procedures should follow institutional research protocols.
Each production batch undergoes analytical verification procedures including:
These procedures support consistent analytical standards for research applications.
Sequence and molecular specifications for each component are provided in batch documentation.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
A high-concentration, long-acting GLP-1 receptor agonist studied for incretin pathway receptor pharmacology, downstream cAMP signaling cascade dynamics, and multi-arm metabolic endpoint marker quantification in extended institutional research protocols.
Research-grade selective synthetic pentapeptide formulated for experimental peptide interaction research in controlled laboratory settings.
Research-grade synthetic peptide fragment formulated for advanced laboratory peptide research and experimental scientific protocols. Disclosure: This product is intended for research purposes only and is not intended for human consumption...
GHK-Cu (50mg): High-purity copper-coordinated tripeptide complex provided in 50mg format for laboratory research involving metal-binding chemistry and extracellular signaling pathway analysis.
A synthetic 44-amino acid analog of growth hormone-releasing hormone studied for pituitary receptor binding kinetics, GHRH pathway signaling dynamics, and downstream somatotropic axis marker activity in controlled preclinical models.
